Janni Mirosevich

Vanderbilt University Medical Center — United States

Medicine · Health Sciences

13h-index1.8kcitations27works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(14), FOXO transcription factor regulation(7), Sperm and Testicular Function(3), Advanced biosensing and bioanalysis techniques(3), DNA and Nucleic Acid Chemistry(3)

Publications27 total

Increased nuclear factor I/B expression in prostate cancer correlates with AR expression
The Prostate·2020· 17 citedOpen Access
Active Nanoparticle Targeting: Current Status and Future Challenges
2019
Increased nuclear factor I/B expression in prostate cancer correlates with AR expression
2019· 3 citedOpen Access
Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression
Oncotarget·2016· 27 citedOpen Access
Synthesis of heterobifunctional polyethylene glycols with azide functionality suitable for “click” chemistry
Journal of Polymer Research·2012· 7 cited
Nonviral gene delivery using poly‐<scp>D</scp>/<scp>L</scp> aspartate‐diethylenetriamine cationic polymers and polyethylene glycol: A two‐step approach
Journal of Polymer Science Part A Polymer Chemistry·2011· 2 cited
Abstract 5408: PEG surface modification of Poly(D/L Asp-DET)/DNA polyplexes greatly increases tumor accumulation and improves biodistribution
Cancer Research·2011
Abstract 599: Development of poly(Asp-DET) cationic polymers for nonviral gene delivery
Cancer Research·2010
The Role of Foxa Proteins in the Regulation of Androgen Receptor Activity
2009· 6 cited
Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
Molecular Cancer Therapeutics·2008· 91 citedOpen Access
Prostate epithelial cell fate
Differentiation·2008· 42 cited
A randomized phase II neoadjuvant trial in patients with stages II-III and inflammatory breast cancer.
Cancer Research·2007· 2 cited
1129: The Expression and Role of Foxatranscription Factor Proteins in Prostate Cancer Progression
The Journal of Urology·2007
Dasatinib (BMS-354825), a novel multi-targeted kinase inhibitor that blocks tumor cell migration and invasion, is a promising therapeutic agent for metastatic prostate cancer
Cancer Research·2006· 2 cited
Investigating the Role of Hepatocyte Nuclear Factor-3 (HNF-3) Alpha and Beta in Prostate Cancer and Cellular Differentiation
2006
Foxa1 and Foxa2 Interact with the Androgen Receptor to Regulate Prostate and Epididymal Genes Differentially
Annals of the New York Academy of Sciences·2005· 99 cited
Action of the Src Family Kinase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells
Cancer Research·2005· 371 citedOpen Access
Expression and role of Foxa proteins in prostate cancer
The Prostate·2005· 135 cited
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation
Development·2005· 191 cited
Coupled analysis of gene expression and chromosomal location
Genomics·2005· 54 cited
page 1 of 2Next →

Frequent Co-authors

Robert J. Matusik(11), Richard Jove(6), Aparna Gupta(6), Nan Gao(4), Thomas C. Case(4), Xiuping Yu(4), Grégoire Cardoen(4), Brian J. Burke(4), Kevin Sill(4), Sangkil Nam(3), Ralf Buettner(3), Yongqing Wang(3), Scott B. Shappell(3), Magdalena M. Grabowska(3), Justin Cates(3), Donghwa Kim(2), Jin Cheng(2), Shumin Zhang(2), Ji‐Hyun Lee(2), Richard Roberts(2)